Affordable Access

Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy.

Authors
Type
Published Article
Journal
Expert Opinion on Investigational Drugs
1744-7658
Publisher
Informa UK (Taylor & Francis)
Publication Date
Volume
16
Issue
4
Pages
419–429
Identifiers
PMID: 17371191
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments